NCM
Nantahala Capital Management’s Akebia Therapeutics AKBA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.28M | Hold |
2,000,000
| – | – | 0.29% | 55 |
|
|
2025
Q1 | $3.84M | Buy |
+2,000,000
| New | +$3.84M | 0.15% | 73 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 106 |
|
|
2022
Q1 | – | Sell |
-4,918,565
| Closed | -$11.1M | – | 108 |
|
|
2021
Q4 | $11.1M | Sell |
4,918,565
-59,630
| -1% | -$135K | 0.39% | 38 |
|
|
2021
Q3 | $14.3M | Sell |
4,978,195
-191,868
| -4% | -$553K | 0.45% | 38 |
|
|
2021
Q2 | $19.6M | Buy |
5,170,063
+19,244
| +0.4% | +$72.9K | 0.56% | 29 |
|
|
2021
Q1 | $17.4M | Sell |
5,150,819
-1,889,668
| -27% | -$6.4M | 0.51% | 33 |
|
|
2020
Q4 | $19.7M | Buy |
7,040,487
+1,293,864
| +23% | +$3.62M | 0.61% | 34 |
|
|
2020
Q3 | $14.4M | Sell |
5,746,623
-354,488
| -6% | -$890K | 0.44% | 40 |
|
|
2020
Q2 | $82.9M | Sell |
6,101,111
-458,367
| -7% | -$6.22M | 2.5% | 1 |
|
|
2020
Q1 | $49.7M | Sell |
6,559,478
-177,642
| -3% | -$1.35M | 1.86% | 5 |
|
|
2019
Q4 | $42.6M | Buy |
6,737,120
+947,559
| +16% | +$5.99M | 1.31% | 11 |
|
|
2019
Q3 | $22.7M | Hold |
5,789,561
| – | – | 0.84% | 19 |
|
|
2019
Q2 | $28M | Buy |
5,789,561
+848,500
| +17% | +$4.11M | 0.86% | 18 |
|
|
2019
Q1 | $40.5M | Sell |
4,941,061
-123,028
| -2% | -$1.01M | 1.26% | 12 |
|
|
2018
Q4 | $28M | Buy |
5,064,089
+339,878
| +7% | +$1.88M | 0.86% | 17 |
|
|
2018
Q3 | $41.7M | Buy |
4,724,211
+201,100
| +4% | +$1.78M | 1.12% | 14 |
|
|
2018
Q2 | $45.1M | Buy |
4,523,111
+1,136,968
| +34% | +$11.3M | 1.83% | 10 |
|
|
2018
Q1 | $32.3M | Buy |
3,386,143
+1,452,276
| +75% | +$13.8M | 1.45% | 11 |
|
|
2017
Q4 | $28.8M | Buy |
1,933,867
+565,920
| +41% | +$8.42M | 1.28% | 8 |
|
|
2017
Q3 | $26.9M | Sell |
1,367,947
-780,676
| -36% | -$15.4M | 1.32% | 9 |
|
|
2017
Q2 | $30.9M | Sell |
2,148,623
-131,908
| -6% | -$1.9M | 2.45% | 8 |
|
|
2017
Q1 | $21M | Buy |
2,280,531
+48,123
| +2% | +$443K | 2.34% | 7 |
|
|
2016
Q4 | $23.2M | Buy |
2,232,408
+317,400
| +17% | +$3.3M | 2.41% | 9 |
|
|
2016
Q3 | $17.3M | Buy |
1,915,008
+234,618
| +14% | +$2.12M | 2.09% | 12 |
|
|
2016
Q2 | $12.6M | Buy |
1,680,390
+333,064
| +25% | +$2.49M | 1.36% | 16 |
|
|
2016
Q1 | $12.1M | Buy |
1,347,326
+1,125,652
| +508% | +$10.1M | 1.25% | 18 |
|
|
2015
Q4 | $2.86M | Buy |
+221,674
| New | +$2.86M | 0.37% | 43 |
|